Ignite Creation Date:
2024-05-06 @ 12:20 PM
Last Modification Date:
2024-10-26 @ 12:57 PM
Study NCT ID:
NCT03735875
Status:
TERMINATED
Last Update Posted:
2023-10-16
First Post:
2018-11-02
Brief Title:
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Acute Leukemia |
| Acute Myeloid Leukemia With FLT3ITD Mutation |
| Recurrent Acute Myeloid Leukemia |
Keywords: